Literature DB >> 16393292

Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.

N Hoepffner1, Y M Shastri, E Hanisch, W Rösch, J Mössner, W F Caspary, J Stein.   

Abstract

BACKGROUND: Faecal occult blood testing is an established method of colorectal neoplasia screening. Guaiac-based tests are limited by poor patient compliance, low sensitivity, specificity and positive predictive value. Newer immunochemical-based tests, accurate but tedious, require a well-established laboratory set up. There is need for simpler immunochemical tests that can be performed at the out-patient clinic. AIM: To compare the performance characteristics of a new bedside immunological test strip device with a sensitive Guaiac-based and established immunochemical test for detection of faecal occult blood in patients undergoing colonoscopy.
METHODS: A total of 389 consecutive patients from four centres who were referred for colonoscopy also provided the stool samples for detection of occult blood without dietary restrictions. Stool tests performed were (i) Guaiac-based, (ii) immunochemical enzyme-linked immunosorbent assay and (iii) bedside immunochemical strip test.
RESULTS: At the optimal threshold level, the sensitivity and specificity of the beside immunochemical strip test for detection of significant colorectal neoplasia (adenomas >1.0 cm and carcinomas) were 60% and 95%, respectively.
CONCLUSIONS: This bedside immunochemical strip test proved to be a simple, convenient, non-cumbersome and accurate tool with similar performance characteristics for detection of any bleeding lesion including colorectal neoplasia when compared with an established immunochemical faecal occult blood test.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393292     DOI: 10.1111/j.1365-2036.2006.02702.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

Review 1.  Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis.

Authors:  Alan S Rosman; Mark A Korsten
Journal:  J Gen Intern Med       Date:  2010-05-25       Impact factor: 5.128

2.  Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance.

Authors: 
Journal:  CADTH Technol Overv       Date:  2010-09-01

Review 3.  Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.

Authors:  Jeremy R Huddy; Melody Z Ni; Sheraz R Markar; George B Hanna
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  Cost-effectiveness of colorectal cancer screening - an overview.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-08       Impact factor: 3.043

5.  Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.

Authors:  Adolfo Parra-Blanco; Antonio Z Gimeno-García; Enrique Quintero; David Nicolás; Santiago G Moreno; Alejandro Jiménez; Manuel Hernández-Guerra; Marta Carrillo-Palau; Yoshinobu Eishi; Julio López-Bastida
Journal:  J Gastroenterol       Date:  2010-02-17       Impact factor: 7.527

Review 6.  Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.

Authors:  Esmée J Grobbee; Pieter Ha Wisse; Eline H Schreuders; Aafke van Roon; Leonie van Dam; Ann G Zauber; Iris Lansdorp-Vogelaar; Wichor Bramer; Sarah Berhane; Jonathan J Deeks; Ewout W Steyerberg; Monique E van Leerdam; Manon Cw Spaander; Ernst J Kuipers
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

7.  New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 one of the options?

Authors:  Y M Shastri; J M Stein
Journal:  Br J Cancer       Date:  2007-10-23       Impact factor: 7.640

8.  Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska Native population with high prevalence of Helicobacter pylori infection, 2008-2012.

Authors:  Diana Redwood; Ellen Provost; Elvin Asay; Diana Roberts; Donald Haverkamp; David Perdue; Michael G Bruce; Frank Sacco; David Espey
Journal:  Prev Chronic Dis       Date:  2014-04-10       Impact factor: 2.830

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.